[Ac 225]RTX-2358 / Ratio Therap - LARVOL DELTA

ATLAS: Actinium Therapy for Late-stage Aggressive Sarcomas (clinicaltrials.gov) - P1 | N=26 | Recruiting | Sponsor: Ratio Therapeutics, Inc. | Not yet recruiting ➔ Recruiting

Enrollment open • Oncology • Sarcoma • Soft Tissue Sarcoma • Solid Tumor

A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS (CTOS 2025) - "N/A"

Oncology • Sarcoma • Soft Tissue Sarcoma • Solid Tumor • CAFs • FAP